In addition to these specific genes, we identified a strong positive correlation between CDH3 and genes involved in cell migration (AMOTL2 [69] and BCL11B [70]] and stemness capacity [SOX10 [71] and EPCAM [72]) in GBM patients, further supporting our in vitro data. This evidence concerns the gene BCL11B and glioblastoma.